DAPSONE 8.5% / NIACINAMIDE 4%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2019-04-23
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:25
Label at a glance#
ProductDAPSONE 8.5% / NIACINAMIDE 4%
Active ingredientDAPSONE, NIACINAMIDE
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC adverse reactions.
Active, inactive
NDC 72934-1066-2 DAPSONE 8.5 / NIACINAMIDE 4 Gel 30gm
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DAPSONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4ae3f83f-9ccb-db71-5718-0b1e959868df | Product name | 5 | 20260113 |
| 5ae2790a-f798-4a69-8811-64a4723c389a | Product name | 5 | 20250325 |
| b8929bfc-0002-d39a-046d-72ddf714efbe | Product name | 6 | 20190618 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-1066-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3b3a-a910-e053-dadaa90a0b85 | DAPSONE 8.5% / NIACINAMIDE 4% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-1066-2 | DAPSONE 8.5% / NIACINAMIDE 4% | 30 g in 1 BOTTLE, PUMP | GEL | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-1066 | DAPSONE 8.5% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190501_8738b667-e55b-5543-e053-2991aa0a5530.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72934-1066-2 | GM - Gram | 72934-1066 | 7bb7b23d-2a39-434a-b276-ff74cd476f32 | 1 | 2020-02-13 |
Products#
Every source-derived product name is available through these pages.
- DAPSONE 8.5% / NIACINAMIDE 4%
- DAPSONE
- NIACINAMIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-1066 | 72934-1066-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DAPSONE | 8W5C518302 | ACTIB |
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8738b667-e55c-5543-e053-2991aa0a5530 | 8738b667-e55b-5543-e053-2991aa0a5530 | 2019-04-23 | Adverse reactions | 8738b667-e55c-5543-e053-2991aa0a5530 8738b667-e55b-5543-e053-2991aa0a5530 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


